Acute-on chronic liver failure

Journal of Hepatology

Volumn 57, Issue 6, 2012, Pages 1336-1348

  Jalan, Rajiv ^a   Gines, Pere ^b,f   Olson, Jody C ^c   Mookerjee, Rajeshwar P ^a   Moreau, Richard ^d   Garcia Tsao, Guadalupe ^e   Arroyo, Vicente ^b,f   Kamath, Patrick S ^c  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BARCELONA   (Spain)

^c MAYO CLINIC   (United States)

^d CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Acute on chronic liver failure; Hepatic encephalopathy; Hepatorenal syndrome; Immune failure; Liver support; Liver transplantation

Indexed keywords

ACETYLCYSTEINE; ALBUMIN; BIOLOGICAL MARKER; CASPASE INHIBITOR; CYTOKINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NORFLOXACIN; PENTOXIFYLLINE; PHOSPHODIESTERASE V INHIBITOR; QUINOLONE DERIVATIVE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RIFAXIMIN; SILDENAFIL; TENOFOVIR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 2; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACUTE ON CHRONIC LIVER FAILURE; ALCOHOL LIVER DISEASE; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ARTIFICIAL VENTILATION; ASCITES; BLOOD CHEMISTRY; BLOOD CLOTTING DISORDER; CLINICAL FEATURE; CYTOKINE PRODUCTION; DECOMPENSATED LIVER CIRRHOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; ENZYME ACTIVITY; EPIDEMIOLOGICAL DATA; HEMODYNAMICS; HEPATITIS B; HEPATITIS B VIRUS; HEPATORENAL SYNDROME; HISTOPATHOLOGY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERBILIRUBINEMIA; INFLAMMATION; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER TRANSPLANTATION; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SEPTIC SHOCK; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TOXIC HEPATITIS; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT INDICATION; VASOCONSTRICTION; VIRUS HEPATITIS;

ACUTE DISEASE; BRAIN; END STAGE LIVER DISEASE; HEMODYNAMICS; HUMANS; KIDNEY; LIVER; LIVER TRANSPLANTATION; PROGNOSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84869213874     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.06.026     Document Type: Review

References (142)

1. R. Jalan, and R. Williams Acute-on-chronic liver failure: pathophysiological basis of therapeutic options Blood Purif 20 2002 252 261
2. S.K. Sarin, A. Kumar, J.A. Almeida, Y.K. Chawla, S.T. Fan, and H. Garg Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) Hepatol Int 3 2009 269 282
3. J.C. Olson, J.A. Wendon, D.J. Kramer, A. Vicente, R. Jalan, and G. Garcia-Tsao Intensive care of the patient with cirrhosis Hepatology 54 2011 1864 1872
4. R. Jalan, V. Stadlbauer, S. Sen, R. Mookerjee, N. Davies, and S. Hodges Natural history of acute decompensation of cirrhosis: the basis of the definition, prognosis, and pathophysiology of acute-on-chronic liver failure Hepatology 44 Suppl. 1 2006 371A 372A
5. R. Jalan, S. Sen, and R. Williams Prospects for extracorporeal liver support Gut 53 2004 890 898
6. R.N. Pugh, I.M. Murray-Lyon, J.L. Dawson, M.C. Pietroni, and R. Williams Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 1973 646 649
7. P.S. Kamath, R.H. Wiesner, M. Malinchoc, W. Kremers, T.M. Therneau, and C.L. Kosberg A model to predict survival in patients with end-stage liver disease Hepatology 33 2001 464 470
8. J.L. Vincent, R. Moreno, J. Takala, S. Willatts, A. De Mendonca, and H. Bruining The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine Intensive Care Med 22 1996 707 710
9. W.A. Knaus, E.A. Draper, D.P. Wagner, and J.E. Zimmerman APACHE II: a severity of disease classification system Crit Care Med 13 1985 818 829
10. G. Goldfarb, O. Nouel, T. Poynard, and B. Rueff Efficiency of respiratory assistance in cirrhotic patients with liver failure Intensive Care Med 9 1983 271 273
11. R.G. Shellman, W.J. Fulkerson, E. DeLong, and C.A. Piantadosi Prognosis of patients with cirrhosis and chronic liver disease admitted to the medical intensive care unit Crit Care Med 16 1988 671 678
12. C.A. Zauner, R.C. Apsner, A. Kranz, L. Kramer, C. Madl, and B. Schneider Outcome prediction for patients with cirrhosis of the liver in a medical ICU: a comparison of the APACHE scores and liver-specific scoringsystems Intensive Care Med 22 1996 559 563
13. J.E. Zimmerman, D.P. Wagner, M.G. Seneff, R.B. Becker, X. Sun, and W.A. Knaus Intensive care unit admissions with cirrhosis: risk-stratifying patient groups and predicting individual survival Hepatology 23 1996 1393 1401
14. K.C. Lee, and A.A. Chiang The outcome of terminal liver cirrhosis patients requiring mechanical ventilation Zhonghua Yi Xue Za Zhi (Taipei) 59 1997 88 94
15. N. Singh, T. Gayowski, M.M. Wagener, and I.R. Marino Outcome of patients with cirrhosis requiring intensive care unit support: prospective assessment of predictors of mortality J Gastroenterol 33 1998 73 79
16. J.P. Kress, A. Rubin, A.S. Pohlman, and J.B. Hall Outcomes of critically ill patients denied consideration for liver transplantation Am J Respir Crit Care Med 162 2000 418 423
17. A. Aggarwal, J.P. Ong, Z.M. Younossi, D.R. Nelson, L. Hoffman-Hogg, and A.C. Arroliga Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU Chest 119 2001 1489 1497
18. M. Wehler, J. Kokoska, U. Reulbach, E.G. Hahn, and R. Strauss Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems Hepatology 34 2001 255 261
19. M.H. Tsai, Y.C. Chen, Y.P. Ho, J.T. Fang, J.M. Lien, and C.T. Chiu Organ system failure scoring system can predict hospital mortality in critically ill cirrhotic patients J Clin Gastroenterol 37 2003 251 257
20. M.H. Tsai, Y.S. Peng, J.M. Lien, H.H. Weng, Y.P. Ho, and C. Yang Multiple organ system failure in critically ill cirrhotic patients. A comparison of two multiple organ dysfunction/failure scoring systems Digestion 69 2004 190 200
21. Y.C. Chen, M.H. Tsai, Y.P. Ho, C.W. Hsu, H.H. Lin, and J.T. Fang Comparison of the severity of illness scoring systems for critically ill cirrhotic patients with renal failure Clin Nephrol 61 2004 111 118
22. Y.C. Chen, M.H. Tsai, C.W. Hsu, Y.P. Ho, J.M. Lien, and M.Y. Chang Role of serum creatinine and prognostic scoring systems in assessing hospital mortality in critically ill cirrhotic patients with upper gastrointestinal bleeding J Nephrol 16 2003 558 565
23. Y.P. Ho, Y.C. Chen, C. Yang, J.M. Lien, Y.Y. Chu, and J.T. Fang Outcome prediction for critically ill cirrhotic patients: a comparison of APACHE II and Child-Pugh scoring systems J Intensive Care Med 19 2004 105 110
24. T.R. Gildea, W.C. Cook, D.R. Nelson, A. Aggarwal, W. Carey, and Z.M. Younossi Predictors of long-term mortality in patients with cirrhosis of the liver admitted to a medical ICU Chest 126 2004 1598 1603
25. E. Cholongitas, M. Senzolo, D. Patch, K. Kwong, V. Nikolopoulou, and G. Leandro Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit Aliment Pharmacol Ther 23 2006 883 893
26. B. Afessa, and P.S. Kubilis Upper gastrointestinal bleeding in patients with hepatic cirrhosis: clinical course and mortality prediction Am J Gastroenterol 95 2000 484 489
27. C. Rabe, V. Schmitz, M. Paashaus, A. Musch, H. Zickermann, and F.L. Dumoulin Does intubation really equal death in cirrhotic patients? Factors influencing outcome in patients with liver cirrhosis requiring mechanical ventilation Intensive Care Med 30 2004 1564 1571
28. D. du Cheyron, B. Bouchet, J.J. Parienti, M. Ramakers, and P. Charbonneau The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis Intensive Care Med 31 2005 1693 1699
29. W.A. Knaus, D.P. Wagner, E.A. Draper, J.E. Zimmerman, M. Bergner, and P.G. Bastos The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults Chest 100 1991 1619 1636
30. Y. Arabi, Q.A. Ahmed, S. Haddad, A. Aljumah, and A. Al-Shimemeri Outcome predictors of cirrhosis patients admitted to the intensive care unit Eur J Gastroenterol Hepatol 16 2004 333 339
31. I.J. Mackle, D.G. Swann, and B. Cook One year outcome of intensive care patients with decompensated alcoholic liver disease Br J Anaesth 97 2006 496 498
32. Y.C. Chen, Y.C. Tian, N.J. Liu, Y.P. Ho, C. Yang, and Y.Y. Chu Prospective cohort study comparing sequential organ failure assessment and acute physiology, age, chronic health evaluation III scoring systems for hospital mortality prediction in critically ill cirrhotic patients Int J Clin Pract 60 2006 160 166
33. C.C. Jenq, M.H. Tsai, Y.C. Tian, C.Y. Lin, C. Yang, and N.J. Liu RIFLE classification can predict short-term prognosis in critically ill cirrhotic patients Intensive Care Med 33 2007 1921 1930
34. E. Cholongitas, A. Betrosian, M. Senzolo, S. Shaw, D. Patch, and P. Manousou Prognostic models in cirrhotics admitted to intensive care units better predict outcome when assessed at 48 h after admission Gastroenterol Hepatol 23 2008 1223 1227
35. J.T. Fang, M.H. Tsai, Y.C. Tian, C.C. Jenq, C.Y. Lin, and Y.C. Chen Outcome predictors and new score of critically ill cirrhotic patients with acute renal failure Nephrol Dial Transplant 23 2008 1961 1969
36. D. Juneja, P.B. Gopal, D. Kapoor, R. Raya, M. Sathyanarayanan, and P. Malhotra Outcome of patients with liver cirrhosis admitted to a specialty liver intensive care unit in India J Crit Care 24 2009 387 393
37. E. Cholongitas, V. Calvaruso, M. Senzolo, D. Patch, S. Shaw, and J. O'Beirne RIFLE classification as predictive factor of mortality in patients with cirrhosis admitted to intensive care unit J Gastroenterol Hepatol 24 2009 1639 1647
38. S.J. Thomson, C. Moran, M.L. Cowan, S. Musa, R. Beale, and D. Treacher Outcomes of critically ill patients with cirrhosis admitted to intensive care: an important perspective from the non-transplant setting Aliment Pharmacol Ther 32 2010 233 243
39. B. Filloux, C. Chagneau-Derrode, S. Ragot, J. Voultoury, M. Beauchant, and C. Silvain Short-term and long-term vital outcomes of cirrhotic patients admitted to an intensive care unit Eur J Gastroenterol Hepatol 22 2010 1474 1480
40. Juneja D, Gopal PB, Kapoor D, Raya R, Sathyanarayanan M. Profiles and outcome of patients with liver cirrhosis requiring mechanical ventilation. J Intensive Care Med (in press).
41. P. Feltracco, M. Brezzi, S. Barbieri, M. Milevoj, H. Galligioni, and U. Cillo Intensive care unit admission of decompensated cirrhotic patients: prognostic scoring systems Transplant Proc 43 2011 1079 1084
42. E. Levesque, E. Hoti, D. Azoulay, P. Ichaï, H. Habouchi, and D. Castaing Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit J Hepatol 56 2012 95 102
43. R. Cavallazzi, O.O. Awe, T.S. Vasu, A. Hirani, U. Vaid, and B.E. Leiby Model for End-stage liver disease score for predicting outcome in critically ill medical patients with liver cirrhosis J Crit Care 27 2012 424.e1 424.e6
44. D.L. Shawcross, M.J. Austin, R.D. Abeles, M.J. McPhail, A.D. Yeoman, and N.J. Taylor The impact of organ dysfunction in cirrhosis: survival at a cost? J Hepatol 56 2012 1054 1062
45. R.P. Moreno, B. Metnitz, L. Adler, A. Hoechtl, P. Bauer, and P.G. Metnitz SAPS 3 Investigators. Sepsis mortality prediction based on predisposition, infection and response Intensive Care Med 34 2008 496 504
46. M. Plataki, and R.D. Hubmayr The physical basis of ventilator-induced lung injury Expert Rev Respir Med 4 2010 373 385
47. S.H. Teh, D.M. Nagorney, S.R. Stevens, K.P. Offord, T.M. Therneau, and D.J. Plevak Risk factors for mortality after surgery in patients with cirrhosis Gastroenterology 132 2007 1261 1269
48. E.B. Keeffe Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? Am J Gastroenterol 90 1995 201 205
49. S. Kumar Acharya, P. Kumar Sharma, R. Singh, S. Kumar Mohanty, K. Madan, and J. Kumar Jha Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death J Hepatol 46 2007 387 394
50. R. Loomba, A. Rowley, R. Wesley, T.J. Liang, J.H. Hoofnagle, and F. Pucino Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy Ann Intern Med 148 2008 519 528
51. W.F. Carman, J. Korula, L. Wallace, R. MacPhee, L. Mimms, and R. Decker Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA Lancet 345 1995 1406 1407
52. H. Garg, S.K. Sarin, M. Kumar, V. Garg, B.C. Sharma, and A. Kumar Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure Hepatology 53 2011 774 780
53. B. Bernard, J.D. Grange, E.N. Khac, X. Amiot, P. Opolon, and T. Poynard Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis Hepatology 29 1999 1655 1661
54. A. Monescillo, F. Martínez-Lagares, L. Ruiz-del-Arbol, A. Sierra, C. Guevara, and E. Jiménez Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding Hepatology 40 2004 793 801
55. J.C. García-Pagán, K. Caca, C. Bureau, W. Laleman, B. Appenrodt, and A. Luca Early TIPS (Transjugular Intrahepatic Portosystemic Shunt) Cooperative Study Group. Early use of TIPS in patients with cirrhosis and variceal bleeding N Engl J Med 362 2010 2370 2379
56. R. Malik, R.P. Mookerjee, and R. Jalan Infection and inflammation in liver failure: two sides of the same coin J Hepatol 51 2009 426 429
57. N. Rolando, J. Wade, M. Davalos, J. Wendon, J. Philpott-Howard, and R. Williams The systemic inflammatory response syndrome in acute liver failure Hepatology 32 2000 734 739
58. J. Vaquero, J. Polson, C. Chung, I. Helenowski, F.V. Schiodt, and J. Reisch Infection and the progression of hepatic encephalopathy in acute liver failure Gastroenterology 125 2003 755 764
59. R. Jalan, S.W. Olde Damink, P.C. Hayes, N.E. Deutz, and A. Lee Pathogenesis of intracranial hypertension in acute liver failure: inflammation, ammonia and cerebral blood flow J Hepatol 41 2004 613 620
60. T. Gustot Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response Curr Opin Crit Care 17 2011 153 159
61. S. Sen, N.A. Davies, R.P. Mookerjee, L.M. Cheshire, S.J. Hodges, and R. Williams Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study Liver Transpl 10 2004 1109 1119
62. M. Cazzaniga, E. Dionigi, G. Gobbo, A. Fioretti, V. Monti, and F. Salerno The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome J Hepatol 51 2009 475 482
63. D. Thabut, J. Massard, A. Gangloff, N. Carbonell, C. Francoz, and E. Nguyen-Khac Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure Hepatology 46 2007 1872 1882
64. S. Naveau, S. Chollet-Martin, S. Dharancy, P. Mathurin, P. Jouet, and M.A. Piquet Foie-alcool group of the association Française pour l'Etude du Foie. A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis Hepatology 39 2004 1390 1397
65. N.C. Boetticher, C.J. Peine, P. Kwo, G.A. Abrams, T. Patel, and B. Aqel A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis Gastroenterology 135 2008 1953 1960
66. G. Linderoth, P. Jepsen, and H.C. Schonheyder Short-term prognosis of community-acquired bacteremia in patients with liver cirrhosis or alcoholism: a population-based cohort study Alcohol Clin Exp Res 30 2006 636 641
67. M. Borzio, F. Salerno, and L. Piantoni Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study Dig Liver Dis 33 2001 41 48
68. P. Montalto, J. Vlachogiannakos, D.J. Cox, S. Pastacaldi, D. Patch, and A.K. Burroughs Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study J Hepatol 37 2002 463 470
69. V. Arvaniti, G. D'Amico, G. Fede, P. Manousou, E. Tsochatzis, and M. Pleguezuelo Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis Gastroenterology 139 2010 1246 1256
70. T. Gustot, F. Durand, D. Lebrec, J.L. Vincent, and R. Moreau Severe sepsis in cirrhosis Hepatology 50 2009 2022 2033
71. H.E. Wasmuth, D. Kunz, and E. Yagmur Patients with acute on chronic liver failure display "sepsis-like" immune paralysis J Hepatol 42 2005 195 201
72. R.P. Mookerjee, V. Stadlbauer, S. Lidder, G.A. Wright, S.J. Hodges, and N.A. Davies Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts outcome Hepatology 46 2007 831 840
73. P.A. Berry, C.G. Antoniades, I. Carey, M.J. McPhail, M.J. Hussain, and E.T. Davies Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis Intensive Care Med 37 2011 453 460
74. H.D. Nischalke, C. Berger, K. Aldenhoff, L. Thyssen, M. Gentemann, and F. Grünhage Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis J Hepatol 55 2011 1010 1016
75. V. Stadlbauer, R.P. Mookerjee, S. Hodges, G.A. Wright, N.A. Davies, and R. Jalan Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis J Hepatol 48 2008 945 951
76. V. Garg, H. Garg, A. Khan, N. Trehanpati, A. Kumar, and B.C. Sharma Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure Gastroenterology 142 2012 505 512
77. A. Katoonizadeh, W. Laleman, C. Verslype, A. Wilmer, G. Maleux, and T. Roskams Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study Gut 59 2010 1561 1569
78. R. Jalan, and R.P. Mookerjee Acute-on-chronic liver failure: an early biopsy is essential? Gut 59 2010 1455 1456
79. R.P. Mookerjee, C. Lackner, R. Stauber, V. Stadlbauer, M. Deheragoda, and A. Aigelsreiter The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis J Hepatol 55 2011 1103 1111
80. D. Adebayo, R.P. Mookerjee, and R. Jalan Mechanistic biomarkers in acute liver injury: are we there yet? J Hepatol 56 2012 1003 1005
81. R.P. Mookerjee, S. Sen, N.A. Davies, S.J. Hodges, R. Williams, and R. Jalan Tumour necrosis factor α is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis Gut 52 2003 1182 1187
82. D. Benten, and R. Wiest Gut microbiome and intestinal barrier failure - The "Achilles heel" in hepatology? J Hepatol 56 2012 1221 1223
83. J. Vlachogiannakos, A.S. Saveriadis, N. Viazis, I. Theodoropoulos, K. Foudoulis, and S. Manolakopoulos Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis Aliment Pharmacol Ther 29 2009 992 999
84. B. Rasaratnam, D. Kaye, G. Jennings, F. Dudley, and J. Chin-Dusting The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial Ann Intern Med 139 2003 186 193
85. D. Thabut, K.A. Tazi, D. Bonnefont-Rousselot, M. Aller, O. Farges, and M.C. Guimont High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats Hepatology 46 2007 1893 1906
86. B. Laviña, J. Gracia-Sancho, A. Rodríguez-Vilarrupla, Y. Chu, D.D. Heistad, and J. Bosch Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension Gut 58 2009 118 125
87. A. Kumar, K. Das, P. Sharma, V. Mehta, B.C. Sharma, and S.K. Sarin Hemodynamic studies in acute-on-chronic liver failure Dig Dis Sci 54 2009 869 878
88. R. Jalan, and R.P. Mookerjee Systemic hemodynamics, hepatic blood flow and portal pressure in patients with cirrhosis and multiorgan failure: the role of sympathetic activation Hepatology 48 Suppl. 1 2008 1077A
89. R.P. Mookerjee, A. Wiesenthal, A. Icking, S.J. Hodges, N.A. Davies, and K. Schilling Increased gene and protein expression of the novel eNOS regulatory protein NOSTRIN and a variant in alcoholic hepatitis Gastroenterology 132 2007 2533 2541
90. V. Shah, F.G. Haddad, G. Garcia-Cardena, J.A. Frangos, A. Mennone, and R.J. Groszmann Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids J Clin Invest 100 1997 2923 2930
91. R.P. Mookerjee, M. Malaki, N.A. Davies, S.J. Hodges, R.N. Dalton, and C. Turner Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis Hepatology 45 2007 62 71
92. K.C. Lee, Y.Y. Yang, Y.W. Wang, M.C. Hou, F.Y. Lee, and H.C. Lin Acute administration of sildenafil enhances hepatic cyclic guanosine monophosphate production and reduces hepatic sinusoid resistance in cirrhotic patients Hepatol Res 38 2008 1186 1193
93. P. Gines, and R.W. Schrier Renal failure in cirrhosis N Engl J Med 361 2009 1279 1290
94. M. Martín-Llahí, M. Guevara, A. Torre, C. Fagundes, T. Restuccia, and R. Gilabert Prognostic importance of the cause of renal failure in patients with cirrhosis Gastroenterology 140 2011 488 496
95. V. Stadlbauer, G. Wright, M. Banaji, A. Mukhopadhyay, R. Mookerjee, and K. Moore Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis Gastroenterology 134 2008 111 119
96. A. Nazar, G.H. Pereira, M. Guevara, M. Martín-Llahi, M.N. Pepin, and M. Marinelli Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome Hepatology 51 2010 219 226
97. M.K. Nadim, Y.S. Genyk, C. Tokin, J. Fieber, W. Ananthapanyasut, and W. Ye Impact of etiology of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis versus hepatorenal syndrome Liver Transpl 18 2012 539 548
98. S. Holt, D. Goodier, R. Marley, D. Patch, A. Burroughs, and B. Fernando Improvement in renal function in hepatorenal syndrome with N-acetylcysteine Lancet 353 1999 294 295
99. E. Akriviadis, R. Bolta, and W. Briggs Pentoxifylline improves short-term survival in severe alcoholic hepatitis: a double-blind, placebo-controlled trial Gastroenterology 119 2000 1637 1648
100. P. Sort, M. Navasa, V. Arroyo, X. Aldeguer, R. Planas, and L. Ruiz-del-Arbol Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis N Engl J Med 5 341 1999 403 409
101. R. Ortega, P. Ginès, J. Uriz, A. Cárdenas, B. Calahorra, and D. De Las Heras Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study Hepatology 36 2002 941 948
102. J. Fernàndez, M. Navasa, and R. Planas Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis Gastroenterology 133 2007 818 824
103. N. Shah, and D. Dhar El Zahraa Mohammed F, Habtesion A, Davies NA, Jover-Cobos M, et al. Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression J Hepatol 56 2012 1047 1053
104. A. Cárdenas, and P. Ginès Acute-on-chronic liver failure: the kidneys Curr Opin Crit Care 17 2011 184 189
105. J.S. Crippin, J.B. Gross Jr., and K.D. Lindor Increased intracranial pressure and hepatic encephalopathy in chronic liver disease Am J Gastroenterol 87 1992 879 882
106. R. Jalan, K. Dabos, D.N. Redhead, A. Lee, and P.C. Hayes Elevation of intracranial pressure following transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage J Hepatol 27 1997 928 933
107. J.P. Donovan, D.F. Schafer, B.W. Shaw Jr., and M.F. Sorrell Cerebral edema and increased intracranial pressure in chronic liver disease Lancet 351 1998 719 721
108. G. Wright, N.A. Davies, D.L. Shawcross, S.J. Hodges, C. Zwingmann, and H.F. Brooks Endotoxemia produces coma and brain swelling in bile duct ligated rats Hepatology 45 2007 1517 1526
109. R. García Martínez, A. Rovira, J. Alonso, F.X. Aymerich, E. Huerga, and C. Jacas A long-term study of changes in the volume of brain ventricles and white matter lesions after successful liver transplantation Transplantation 89 2010 589 594
110. D.L. Shawcross, Y. Sharifi, J.B. Canavan, A.D. Yeoman, R.D. Abeles, and N.J. Taylor Infection and systemic inflammation, not ammonia, are associated with grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis J Hepatol 54 2011 640 649
111. H.R. Pedersen, H. Ring-Larsen, N.V. Olsen, and F.S. Larsen Hyperammonemia acts synergistically with lipopolysaccharide in inducing changes in cerebral hemodynamics in rats anaesthetised with pentobarbital J Hepatol 47 2007 245 252
112. R. Rodrigo, O. Cauli, U. Gomez-Pinedo, A. Agusti, V. Hernandez-Rabaza, and J.M. Garcia-Verdugo Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy Gastroenterology 139 2010 675 684
113. G. Wright, B. Vairappan, V. Stadlbauer, R.P. Mookerjee, N.A. Davies, and R. Jalan Reduction in hyperammonaemia by ornithine phenylacetate prevents lipopolysaccharide-induced brain edema and coma in cirrhotic rats Liver Int 32 2012 410 419
114. N.M. Bass, K.D. Mullen, A. Sanyal, F. Poordad, G. Neff, and C.B. Leevy Rifaximin treatment in hepatic encephalopathy N Engl J Med 25 362 2010 1071 1081
115. R. Jalan, S.W. Olde Damink, J.C. Ter Steege, D.N. Redhead, A. Lee, and P.C. Hayes Acute endotoxemia following transjugular intrahepatic stent-shunt insertion is associated with systemic and cerebral vasodilatation with increased whole body nitric oxide production in critically ill cirrhotic patients J Hepatol 54 2011 265 271
116. P. Iversen, S. Keiding, K. Mouridsen, P. Ott, and H. Vilstrup Transjugular intrahepatic portosystemic shunt does not alter cerebral blood flow Clin Gastroenterol Hepatol 9 2011 1001 1003
117. A. Helmy, R. Jalan, D.E. Newby, P.C. Hayes, and D.J. Webb Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis Gastroenterology 118 2000 565 572
118. H. Liu, and S.S. Lee Acute-on-chronic liver failure: the heart and systemic hemodynamics Curr Opin Crit Care 17 2011 190 194
119. L. Ruiz-del-Arbol, A. Monescillo, C. Arocena, P. Valer, P. Ginès, and V. Moreira Circulatory function and hepatorenal syndrome in cirrhosis Hepatology 42 2005 439 447
120. J. Fernández, A. Escorsell, M. Zabalza, V. Felipe, M. Navasa, and A. Mas Adrenal insufficiency in patients with cirrhosis and septic shock: effect of treatment with hydrocortisone on survival Hepatology 44 2006 1288 1295
121. S. Moller, E.F. Hansen, U. Becker, K. Brinch, J.H. Henriksen, and F. Bendtsen Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients Liver 20 2000 51 59
122. T. Lisman, F.W. Leebeek, and P.G. de Groot Haemostatic abnormalities in patients with liver disease J Hepatol 37 2002 280 287
123. A. Tripodi, M. Primignani, V. Chantarangkul, A. Dell'Era, M. Clerici, and R. de Franchis An imbalance of pro- vs. anti-coagulation factors in plasma from patients with cirrhosis Gastroenterology 137 2009 2105 2111
124. M. Senzolo, J. Coppell, E. Cholongitas, A. Riddell, C.K. Triantos, and D. Perry The effects of glycosaminoglycans on coagulation: a thromboelastographic study Blood Coagul Fibrinolysis 18 2007 227 236
125. C.H. Jun, C.H. Park, W.S. Lee, Y.E. Joo, H.S. Kim, and S.K. Choi Antibiotic prophylaxis using third generation cephalosporins can reduce the risk of early rebleeding in the first acute gastroesophageal variceal hemorrhage: a prospective randomized study J Korean Med Sci 21 2006 883 890
126. J.B. Segal, and W.H. Dzik Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review Transfusion 45 2005 1413 1425
127. J. Bosch, D. Thabut, A. Albillos, N. Carbonell, J. Spicak, and J. Massard International Study Group on rFVIIa in UGI hemorrhage. recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial Hepatology 47 2008 1604 1614
128. T. Lisman, and R.J. Porte Platelet function in patients with cirrhosis J Hepatol 56 2012 993 994
129. P.M. Mannucci, F. Franchi, and N. Dioguardi Correction of abnormal coagulation in chronic liver disease by combined use of fresh-frozen plasma and prothrombin complex concentrates Lancet 2 7985 1976 542 545
130. R.T. Stravitz, T. Lisman, V.A. Luketic, R.K. Sterling, P. Puri, and M. Fuchs Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography J Hepatol 56 2012 129 136
131. M.H. Tsai, Y.S. Peng, Y.C. Chen, N.J. Liu, Y.P. Ho, and J.T. Fang Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock Hepatology 43 2006 673 681
132. J. Fernandez, A. Escorsell, M. Zabalza, V. Felipe, M. Navasa, and A. Mas Adrenal insufficiency in patients with cirrhosis and septic shock: effect of treatment with hydrocortisone on survival Hepatology 44 2006 1288 1295
133. V. Stadlbauer, N.A. Davies, S. Sen, and R. Jalan Artificial liver support systems in the management of complications of cirrhosis Semin Liver Dis 28 2008 96 109
134. J.Z. Zhong-Ping Duan, S. Xin, M. Ju Chen, D. He, J. Brotherthon, and K. Maxwell Interim results of randomized controlled trial of ELAD in acute on chronic liver disease Hepatology 46 2007 274A
135. J. Stange, S. Mitzner, W. Ramlow, T. Gliesche, H. Hickstein, and R. Schmidt A new procedure for the removal of protein bound drugs and toxins" ASAIO J 39 3 1993 M621 M625
136. R. Jalan, K. Schnurr, R.P. Mookerjee, S. Sen, L. Cheshire, and S. Hodges Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality Hepatology 50 2009 555 564
137. Kribben A, Gerken G, Haag S, Herget-Rosenthal S, Treichel U, Betz C, et al. Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology 2012 (in press).
138. R. Banares, F. Nevens, and F. Larsen Extracorporeal liver support with the molecular adsorbent recirculating system (MARS) in patients with acute-on-chronic liver failure (AOCLF) the RELIEF trial J Hepatol 52 2010 S459
139. R. Bahirwani, O. Shaked, M. Bewtra, K. Forde, and K.R. Reddy Acute-on-chronic liver failure before liver transplantation: impact on posttransplant outcomes Transplantation 92 2011 952 957
140. Z. Chen, T. Wen, Y. Zeng, L. Wang, J.J. Lu, and S. Gong A single institution experience with living donor liver transplantation for acute-on-chronic hepatitis B liver failure Hepatogastroenterology 58 2011 1267 1273
141. Chok KS, Fung JY, Chan SC, Cheung TT, Sharr WW, Chan AC, et al. Outcomes of living-donor liver transplantation in patients with preoperative type-1 hepatorenal syndrome and acute hepatic decompensation. Liver Transpl 2012 (in press).
142. R. Moreau, P. Ginés, R. Jalan, M. Pavesi, F. Durand, and P. Angeli Diagnosis, Prevalence and prognosis of acute-on-chronic liver failure (ACLF): results of the EASL-chronic liver failure consortium CANONIC study J Hepatol 56 Suppl. 2 2012 S552 S553